⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NBTX News
Nanobiotix S.A. American Depositary Shares
NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
globenewswire.com
NBTX
Voting Rights and Shares Capital of the Company
globenewswire.com
NBTX
NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer
globenewswire.com
NBTX
NANOBIOTIX Provides First Half 2026 Operational and Financial Update
globenewswire.com
NBTX
Voting Rights and Shares Capital of the Company
globenewswire.com
NBTX
NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer
globenewswire.com
NBTX
NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
NBTX
Voting Rights and Shares Capital of the Company
globenewswire.com
NBTX
Voting Rights and Shares Capital of the Company
globenewswire.com
NBTX
Voting Rights and Shares Capital of the Company
globenewswire.com
NBTX